WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 87

Legislative bill overview

SB 87 amends Utah's naloxone (opioid overdose reversal medication) laws to expand access and use of the life-saving drug. The bill has passed the Senate and is currently in the House for consideration. Specific amendments would likely address prescribing protocols, standing orders, or immunity protections for administering naloxone.

Why is this important

Naloxone accessibility directly affects overdose survival rates in communities facing opioid crises. Utah has experienced significant opioid-related deaths in recent years, making legislative changes to naloxone availability a public health priority. Expanding access can reduce deaths while the specific protections offered determine whether bystanders, businesses, and medical professionals will feel confident administering it.

Potential points of contention

  • Cost and insurance coverage: Whether naloxone distribution is subsidized or mandated as insurable, affecting affordability and accessibility across income levels
  • Standing order vs. prescription requirements: Whether the bill removes barriers requiring individual prescriptions, which can delay emergency access
  • Liability protections: The scope of immunity for laypeople and organizations administering naloxone without medical training—broader protections encourage use but may concern some stakeholders

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.